Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 19, 2021 10:26am
68 Views
Post# 33729937

RE:RE:RE:RE:RE:RE:Large lawsuit filed against Liminal for some $700,000,000

RE:RE:RE:RE:RE:RE:Large lawsuit filed against Liminal for some $700,000,000 7 boardnames (Newcamo Realstocky Tommyjones CaptSecord Mariadelapena fatcashfast thephantom) and counting by one guy and it's copy and paste the same cash every day. They know they get the cash after 3 month standard processes for anti-competitive stuff but they will not announce another indication until end of year. Lots more time to push it down and evaluate the market that it will go in. Analyst downgrades until then...  Leeds Jones Goble reduced target to $2.50 and will revise again if it continues to fall as they have no indications to do a valuation of the market potential. Smooth move Thomson!


Francois33 wrote: do you realize that more you talk (you and aliases) lower it goes...

Be intelligent, stop talking, we will all do and stock price SHOULD go up.

except if something really fishy is going on...   Try it, wil see.


<< Previous
Bullboard Posts
Next >>